Published in Medicine (Baltimore) on November 01, 2001
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Systemic lupus erythematosus. Orphanet J Rare Dis (2006) 1.36
Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest (2002) 1.19
The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis (2005) 1.17
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis (2004) 1.15
Antiphospholipid antibodies and infections. Ann Rheum Dis (2003) 1.12
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol (2010) 1.08
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis (2004) 1.07
Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis (2006) 1.07
Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis (2003) 1.04
D-dimer level and the risk for thrombosis in systemic lupus erythematosus. Clin J Am Soc Nephrol (2008) 1.00
Antiphospholipid syndrome infectious origin. J Clin Immunol (2004) 1.00
Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. J Cardiothorac Surg (2010) 0.98
All that seems sepsis is not sepsis. Indian J Crit Care Med (2013) 0.96
Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis (2003) 0.94
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis (2005) 0.92
Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clin Rheumatol (2004) 0.91
Treatment of catastrophic antiphospholipid syndrome. Curr Opin Rheumatol (2016) 0.88
Catastrophic antiphospholipid syndrome presenting with sudden renal failure: The lesson lies in vascular lesions. J Nephropathol (2013) 0.87
Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case. Clin Rheumatol (2005) 0.85
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis (2007) 0.85
Management of the antiphospholipid syndrome. Auto Immun Highlights (2010) 0.85
Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol (2006) 0.85
Catastrophic antiphospholipid syndrome presented with severe hypertension, adult respiratory distress syndrome and unilateral adrenal haemorrhagic infarction. Rheumatol Int (2007) 0.81
Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis. Rheumatol Int (2003) 0.81
Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus. Lupus (2012) 0.80
Catastrophic antiphospholipid syndrome in a 7-year-old girl. Clin Rheumatol (2006) 0.80
Catastrophic antiphospholipid syndrome in a 14-year-old child. Pediatr Nephrol (2005) 0.80
Is there a microangiopathic antiphospholipid syndrome? Ann Rheum Dis (2007) 0.79
Kaleidoscope of autoimmune diseases in HIV infection. Rheumatol Int (2016) 0.79
Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies. Clin Rheumatol (2007) 0.77
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome. Clin Rheumatol (2007) 0.76
The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome. Curr Rheumatol Rep (2015) 0.76
Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab. Hippokratia (2010) 0.76
Management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis (2010) 0.76
Hepatic infarction in a pregnant woman with antiphospholipid syndrome and triple antibody positivity: A case report focusing on catastrophic antiphospholipid syndrome. Obstet Gynecol Sci (2016) 0.75
Treatment of the antiphospholipid syndrome. Auto Immun Highlights (2013) 0.75
Autoimmune-related nasal septum perforation: A case report and systematic review. Allergy Rhinol (Providence) (2017) 0.75
Antiphospholipids Syndrome Complicated by a Systemic Capillary Leak-Like Syndrome Treated With Steroids and Intravenous Immunoglobulins: A Case Report. Medicine (Baltimore) (2016) 0.75
Catastrophic antiphospholipid syndrome in a patient with V Leiden variant. Arch Med Sci (2012) 0.75
Catastrophic antiphospholipid syndrome in childhood: presentation with an inferior caval vein mass. BMJ Case Rep (2013) 0.75
Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches. J Immunol Res (2015) 0.75
Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation. Intern Med (2017) 0.75
Catastrophic thromboses and severe thrombocytopenia during heparin therapy in a patient with anti-phospholipid syndrome. Clin Rheumatol (2005) 0.75
Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders. J Neurol (2006) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol (2000) 4.58
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Directed tagging of the Arabidopsis FATTY ACID ELONGATION1 (FAE1) gene with the maize transposon activator. Plant Cell (1995) 4.15
Gene disruption with PCR products in Saccharomyces cerevisiae. Gene (1995) 4.06
Cultivation of the bacillus of Whipple's disease. N Engl J Med (2000) 3.97
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J (1997) 3.67
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med (1997) 3.01
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
A comparison of single-dose dexmedetomidine or propofol on the incidence of emergence delirium in children undergoing general anaesthesia for magnetic resonance imaging. Anaesthesia (2014) 2.74
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
Climatic unpredictability and parasitism of caterpillars: implications of global warming. Proc Natl Acad Sci U S A (2005) 2.65
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 2.35
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 2.31
The key role of nucleosomes in lupus. Arthritis Rheum (1999) 2.26
Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med (1995) 2.26
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med (1996) 2.10
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol (2000) 2.06
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2010) 2.05
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]. Med Clin (Barc) (1994) 2.03
[50 years of LE cells: is it time for their retirement?]. Med Clin (Barc) (1998) 2.02
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus (2008) 2.00
Preferential transposition of the maize element Activator to linked chromosomal locations in tobacco. Plant Cell (1990) 2.00
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) (2001) 1.97
Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol (1992) 1.94
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
Procalcitonin aids diagnosis of adrenocortical failure. Lancet (1997) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol (1995) 1.85
Molecular phylogeny of extant gymnosperms and seed plant evolution: analysis of nuclear 18S rRNA sequences. Mol Biol Evol (1997) 1.85
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum (1999) 1.77
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Higher plant glycosyltransferases. Genome Biol (2001) 1.73
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology (1994) 1.69
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) (2004) 1.68
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation (1991) 1.68
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med (1994) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr (2005) 1.66
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol) (2007) 1.64
Pacemaker infective endocarditis. Am J Cardiol (1998) 1.62